This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Andrews, P. Search for Related Content Social Bookmarking                         What's this?

Review: Renal dysfunction as a marker of increased vascular risk

SW Thames Renal Unit, St Helier Hospital, Carshalton, Surrey, SM5 1AA, UK, peter.andrews{at}epsom-sthelier.nhs.uk

Minimisation of risk factors for the development of vascular disease has made a major contribution to the decline in vascular morbidity and mortality reported over the last decade. Recent evidence has highlighted that elevation of serum creatinine is a strong marker of increased vascular risk, with a predictive value as high as the development of diabetes. As serum creatinine is easily measured — albeit often misinterpreted — this provides another easily applied clinical tool for the stratification of cardiovascular risk and the targeting of preventative medicine in primary and secondary care.

Key Words: serum creatinine • renal impairment • vascular disease • atherosclerosis.

References

• Parfrey JS, Foley RN The clinical epidemiology of cardiac disease in chronic renal failure. J Am Soc Nephrol 1999;10:1606-15.[Free Full Text]
• Goodman WG, Goldin J., Kuizon BD et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 2000;342:1478.[Abstract/Free Full Text]
• Franklin SS, Khan SA, Wong ND et al. Is pulse pressure useful in predicting risk for coronary heart disease? The Framingham Heart Study. Circulation 1999;100:354-60.[Abstract/Free Full Text]
• Levin A., Thompson CR, Ethier J. et al. Left ventricular mass index increase in early renal disease: impact of decline in haemoglobin. Am J Kid Dis 1999;34:125-34.[Medline] [Order article via Infotrieve]
• Culleton BF, Larson MG, Wilson PW et al. Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney Int 1999;56:2214-19.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Wannamethee SG, Shaper AG, Perry IJ Serum creatinine concentration and risk of cardiovascular disease: a possible marker of increased risk of stroke. Stroke 1997;28:557-63.[Abstract/Free Full Text]
• Henry DMA, Kostense PJ, Bos G., Stehouwer CDA. Mild renal insufficiency is associated with increased cardiovascular mortality: the Hoorn Study. Kidney Int 2002;62:1402-07.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• ARIC study. J Am Soc Nephrol 2001;12:225A.
• Mann JF, Gerstein HC, Pogue J., Bosch J., Yusuf S. Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial. Ann Intern Med 2001;134:629-36.[Abstract/Free Full Text]
• Haffner SM, Lehto S., Ronnemaa T., Pylorala K., Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in non-diabetic subjects with and without prior myocardial infarction. N Engl J Med 1998;339:229-34.[Abstract/Free Full Text]
• Ruilope LM, Salvetti A., Jamerson K. et al. Renal function and intensive lowering of blood pressure in hypertensive participants of the hypertension optimal treatment (HOT) study. J Am Soc Nephrol 2001;12:218-25.[Abstract/Free Full Text]
• Shulman NB, Ford CE, Hall WD et al. Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results form the hypertension detection and follow-up programme. The Hypertension Detection and Follow-up Program Cooperative Group. Hypertension 1989;13(suppl 5):180-93.
• Flack JM, Neaton JD, Daniels B. et al. Ethnicity and renal disease: Lessons from the MRFIT trial and the treatment of mild hypertension study. Am J Kidn Dis 1993;21(suppl 1):31-40.[Web of Science][Medline] [Order article via Infotrieve]
• Dinneen SF, Gerstein HC The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systematic overview of the literature. Arch Intern Med 1997;157:1413-18.[Abstract/Free Full Text]
• Viberti G., Chaturvedi N. Angiotensin converting enzyme inhibitors in diabetic patients with microalbuminuria or normoalbuminuria. Kidney Int 1997;63:S32-S35.[CrossRef]
• SIGN. Management of Diabetes. 55, 2001. Edinburgh, Scottish Intercollegiate Guideline Network. www.sign.ac.uk
• The HOPE investigators. Effects of an ACE inhibitor, ramipril, on cardiovascular events in high risk patients. N Engl J Med 2000;342:145-53.[Abstract/Free Full Text]

The British Journal of Diabetes & Vascular Disease, Vol. 4, No. 3, 152-155 (2004)
DOI: 10.1177/14746514040040030301


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Andrews, P. Search for Related Content Social Bookmarking                         What's this?